HB Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.71M | Sell |
10,583
-73
| -0.7% | -$32.5K | 0.04% | 233 |
|
|
2025
Q1 | $5.17M | Buy |
10,656
+1,889
| +22% | +$916K | 0.04% | 221 |
|
|
2024
Q4 | $3.53M | Buy |
8,767
+392
| +5% | +$158K | 0.04% | 202 |
|
|
2024
Q3 | $3.9M | Buy |
8,375
+360
| +4% | +$167K | 0.04% | 181 |
|
|
2024
Q2 | $3.76M | Buy |
8,015
+2,585
| +48% | +$1.21M | 0.04% | 179 |
|
|
2024
Q1 | $2.27M | Buy |
5,430
+1,528
| +39% | +$639K | 0.03% | 225 |
|
|
2023
Q4 | $1.59M | Buy |
3,902
+276
| +8% | +$112K | 0.02% | 256 |
|
|
2023
Q3 | $1.26M | Buy |
3,626
+1,180
| +48% | +$410K | 0.02% | 274 |
|
|
2023
Q2 | $861K | Buy |
2,446
+268
| +12% | +$94.3K | 0.01% | 310 |
|
|
2023
Q1 | $686K | Buy |
2,178
+298
| +16% | +$93.9K | 0.01% | 350 |
|
|
2022
Q4 | $543K | Buy |
1,880
+245
| +15% | +$70.8K | 0.01% | 377 |
|
|
2022
Q3 | $473K | Buy |
1,635
+284
| +21% | +$82.2K | 0.01% | 346 |
|
|
2022
Q2 | $381K | Buy |
+1,351
| New | +$381K | 0.01% | 395 |
|